Atlas Trials

Metastatic Hepatocellular Carcinoma

31 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Hepatocellular Carcinoma

RecordFirmDate
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer (NCT05168163)Academic and Community Cancer Research United2022-05-27
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax (NCT05092373)M.D. Anderson Cancer Center2022-04-29
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies (NCT05003895)National Cancer Institute (NCI)2021-12-08
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484)National Cancer Institute (NCI)2021-11-22
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors (NCT05075993)M.D. Anderson Cancer Center2021-11-12
Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer (NCT04828486)Mayo Clinic2021-08-17
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma (NCT03937830)National Cancer Institute (NCI)2021-03-10
Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment (NCT04511455)Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2020-12-08
Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma (NCT04401800)BeiGene2020-09-04
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers (NCT04221893)University of California, San Francisco2020-08-07
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver (NCT04175912)National Cancer Institute (NCI)2020-03-16
Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC) (NCT03893695)Suzhou Kintor Pharmaceutical Inc,2019-05-25
BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer (NCT03695250)Edward Kim2018-10-16
Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma (NCT00752063)The University of Hong Kong2007-09-01

Track Metastatic Hepatocellular Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.